Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.36 |
| ▸ | MEN1 | O00255 | 1/20 | 0.36 |
| ▸ | LMNA | P02545 | 1/20 | 0.36 |
| ▸ | MAPT | P10636 | 1/20 | 0.36 |
| ▸ | OPRK1 | P41145 | 1/20 | 0.36 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.36 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.36 |
| ▸ | PDK2 | Q15119 | 16/20 | 0.36 |
| ▸ | ESR1 | P03372 | 1/20 | 0.34 |
| ▸ | ESR2 | Q92731 | 1/20 | 0.34 |
| ▸ | THRB | P10828 | 1/20 | 0.33 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.33 |
| ▸ | CYP19A1 | P11511 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5833243 | 1.00 | KDM4E (0.36) | KDM4EMEN1LMNAMAPTOPRK1 | |
| SCHEMBL31312383 | 1.00 | KDM4E (0.36) | KDM4EMEN1LMNAMAPTOPRK1 | |
| SCHEMBL5837635 | 1.00 | KDM4E (0.36) | KDM4EMEN1LMNAMAPTOPRK1 | |
| SCHEMBL12124389 | 1.00 | KDM4E (0.36) | KDM4EMEN1LMNAMAPTOPRK1 | |
| SCHEMBL5833238 | 1.00 | KDM4E (0.36) | KDM4EMEN1LMNAMAPTOPRK1 | |
| SCHEMBL15975762 | 0.94 | PDK2 (0.32) | PDK2 | |
| SCHEMBL5833423 | 0.94 | KDM4E (0.39) | KDM4EMEN1LMNAMAPTOPRK1 | |
| SCHEMBL24293153 | 0.92 | PDK2 (0.33) | KDM4EMEN1LMNAMAPTOPRK1 | |
| SCHEMBL12124336 | 0.92 | PDK2 (0.42) | KDM4EMEN1LMNAMAPTOPRK1 | |
| SCHEMBL13766219 | 0.92 | PDK2 (0.48) | PDK2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20090189519-A1 | Organic electroluminescent compounds and light emitting diode using the same | GRACEL DISPLAY INC. (KR) | 2009-07-30 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090189519-A1 | Organic electroluminescent compounds and light emitting diode using the same | OCIAD1, AOX1, OCIAD2 | KDM4E 2502/4885MEN1 2706/4885LMNA 2608/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.